Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

Ribociclib and Letrozole Treatment in Ovarian Cancer

ClinicalTrials.gov ID: NCT03673124

Public ClinicalTrials.gov record NCT03673124. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.

Study identification

NCT ID
NCT03673124
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
51 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2019 (Actual)
Primary completion
Dec 23, 2024 (Actual)
Completion
Dec 31, 2026 (Estimated)
Last update posted
Dec 23, 2025

2019 – 2026

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
University of California, San Francisco San Francisco California 94158 —
UF Heath Gainesville Florida 32610 —
Moffitt Cancer Center Tampa Florida 33612 —
Northside Hospital Atlanta Georgia 30342 —
NorthShore University HealthSystem Evanston Illinois 60201 —
Saint Vincent Hospital and Health Care Center, Inc. Indianapolis Indiana 46260 —
St. Joseph Mercy Hospital Cancer Care Center Ann Arbor Michigan 48106 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 05055 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
The Valley Hospital Inc. Ridgewood New Jersey 07540 —
New Mexico Cancer Care Alliance/University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87008 —
Southwest Gynecologic Oncology Associates Albuquerque New Mexico 87008 —
Miami Valley Hospital Centerville Ohio 45459 —
The Ohio State Comprehensive Cancer Center Columbus Ohio 43210 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Care Specialists and Research Institute , LLC Tulsa Oklahoma 74146 —
Western Pennsylvania Hospital/West Penn Hospital Pittsburgh Pennsylvania 15224 —
Abington Memorial Hospital Willow Grove Pennsylvania 19090 —
Women & Infants Hospital Providence Rhode Island 02905 —
Parkland Health and Hospital System Dallas Texas 75235 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
MD Anderson Cancer Center Houston Texas 77030 —
Memorial Hermann Texas Medical Center - Texas Medical Center Houston Texas 77030 —
Houston Methodist Willowbrook Hospital Houston Texas 77070 —
Houston Methodist Hospital Houston Texas 77479 —
Houston Methodist Sugar Land Hospital Sugar Land Texas 77479 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03673124, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03673124 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →